Evidence map›Paper›PMID 37962550›Full record

ArticleClinical and experimental immunology2025

Gender-affirming hormone therapy and autoimmunity: new insights from a 3-year follow-up study.

Matteo Marconi, Gloria Riitano, Alessandra Daphne Fisher, Carlotta Cocchetti, Maria Teresa Pagano, Antonella Capozzi, Agostina Longo, Sara D'Arienzo, Linda Vignozzi, Maurizio Sorice and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical and experimental immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Sex Bias in Autoimmunity: New Findings and New Opportunities.JID innovations : skin science from molecules to population health · 2025
    Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Matteo MarconiReference Centre for Gender Medicine, Istituto Superiore di Sanità, Rome, Italy.
Gloria RiitanoDepartment of Experimental Medicine, Sapienza University, Rome, Italy.
Alessandra Daphne FisherAndrology, Women's Endocrinology and Gender Incongruence Unit, Florence University Hospital, Florence, Italy.
Carlotta CocchettiAndrology, Women's Endocrinology and Gender Incongruence Unit, Florence University Hospital, Florence, Italy.
Maria Teresa PaganoDepartment of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.
Antonella CapozziDepartment of Experimental Medicine, Sapienza University, Rome, Italy.
Agostina LongoDepartment of Experimental Medicine, Sapienza University, Rome, Italy.
Sara D'ArienzoRegional Health Agency of Tuscany, Florence, Italy.
Linda VignozziAndrology, Women's Endocrinology and Gender Incongruence Unit, Florence University Hospital, Florence, Italy.ORCID 0000-0003-0907-0630
Maurizio SoriceDepartment of Experimental Medicine, Sapienza University, Rome, Italy.ORCID 0000-0003-3534-1502
Elena OrtonaReference Centre for Gender Medicine, Istituto Superiore di Sanità, Rome, Italy.ORCID 0000-0001-9845-8105
Marina PierdominiciReference Centre for Gender Medicine, Istituto Superiore di Sanità, Rome, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

autoantibodiesautoimmune diseasesgender affirming hormone therapygender medicinetransgender

Identifiers

PMID37962550
PMCPMC11771183

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.